STAT+: Congress probes Emergent’s ties to a key Trump official in wake of Covid-19 vaccine scandal
A pair of top House Democrats is investigating whether Emergent BioSolutions (EBS), which was responsible for contaminating millions of doses of the Johnson & Johnson (JNJ) Covid-19 vaccine, traded on its relationship with a key Trump administration official to win federal contracts.
In a letter to the company, which is one of the biggest contract manufacturers in the pharmaceutical industry, the lawmakers noted they are reacting to reports that Emergent received a $628 million contract last June to create the main U.S. facility for making Covid-19 vaccines for both J&J and AstraZeneca (AZN), despite a history of inadequately trained staff and quality control problems.
